Reimbursement Review Reports

The latest Reimbursement Review reports are posted to this page. Our Reimbursement Reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform non-binding recommendations that help guide the reimbursement decisions of Canada's federal, provincial, and territorial governments, with the exception of Quebec. Implementation advice and funding algorithms are provided where applicable.

For each drug, plasma product, or cell and gene therapy reviewed in the Drug Reimbursement Review process, there is an opportunity for patient groups and clinician groups to provide input and feedback. See Reimbursement Review Open Calls for Input and Feedback.

Brand Name Sort descending Generic Name Therapeutic Area Recommendation Type Project Status Date Submission Received Date Recommendation Issued
Lorbrena Lorlatinib Non-Small Cell Lung Cancer (NSCLC) Do not reimburse Complete
Lotemax Loteprednol etabonate Post-operative inflammation following cataract surgery Do not list Complete
Lucentis Ranibizumab Macular edema, diabetic List with clinical criteria and/or conditions Complete
Lucentis Ranibizumab injection Macular edema, secondary to retinal vein occlusion List with clinical criteria and/or conditions Complete
Lucentis Ranibizumab Myopic choroidal neovascularisation List with criteria/condition Complete
Lucentis Ranibizumab Macular degeneration, age-related List with clinical criteria and/or conditions Complete
Lumakras sotorasib KRAS G12C-mutated advanced NSCLC Do not reimburse Complete
Lutathera lutetium oxodotreotide Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) Reimburse with clinical criteria and/or conditions Complete
Lutathera Lutetium Lu 177 dotatate Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) Reimburse with clinical criteria and/or conditions Complete
Luxturna voretigene neparvovec Vision loss, inherited retinal dystrophy Reimburse with clinical criteria and/or conditions Complete